-
Something wrong with this record ?
Prospective Single-Arm Trial of Endovascular Mechanical Debulking as Initial Therapy in Patients With Acute and Subacute Lower Limb Ischemia: One-Year Outcomes
M. Bulvas, Z. Sommerová, I. Vaněk, J. Weiss,
Language English Country United States
Document type Clinical Trial, Journal Article
- MeSH
- Acute Disease MeSH
- Amputation, Surgical MeSH
- Time Factors MeSH
- Progression-Free Survival MeSH
- Lower Extremity blood supply MeSH
- Adult MeSH
- Endovascular Procedures * adverse effects instrumentation mortality MeSH
- Ischemia diagnostic imaging mortality physiopathology therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Peripheral Arterial Disease diagnostic imaging mortality physiopathology therapy MeSH
- Prospective Studies MeSH
- Vascular Patency MeSH
- Recurrence MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Thrombectomy * adverse effects instrumentation mortality MeSH
- Thrombolytic Therapy MeSH
- Limb Salvage MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Geographicals
- Czech Republic MeSH
PURPOSE: To report the results of a prospective, single-arm study to establish whether the initial treatment of acute or subacute limb ischemia (ALI and SLI, respectively) can be accomplished successfully using endovascular mechanical debulking of the target vessels to avoid the risks associated with thrombolysis and/or open surgery. MATERIALS AND METHODS: From April 2009 to April 2015, 316 consecutive patients (mean age 70.9±12 years; 184 men) with ALI (202, 63.9%) or SLI (114, 36.1%) were enrolled; the only exclusion criterion was irreversible ischemia. The ALI group included 146 (72.3%) participants with category IIb ischemia and 56 (27.7%) with category IIa. Critical limb ischemia was diagnosed in 74 (64.9%) of the 114 patients with SLI. Target occlusions of thrombotic (n=256) or embolic (n=60) origin were located in the femoropopliteal segment (n=231), prosthetic or venous femoropopliteal bypass grafts (n=75), and the aortoiliac segment (n=35). The mean occlusion length was 22.9±14.8 cm. RESULTS: The overall technical success (residual stenosis ≤30%) was 100% after debulking and adjunctive techniques (aspiration, dilation, stenting) at the level of the target lesions. No open surgical or thrombolytic modalities were necessary to bypass or recanalize the target vessels, and no death occurred in association with target occlusion therapy. Additional infrapopliteal interventions were performed in 195 (61.7%) patients (adjunctive thrombolysis in 29) to treat acute, subacute, and chronic lesions. Minor complications directly related to the debulking procedure occurred in 26 (8.2%) patients. Serious complications occurred in 11 (3.5%) patients, including hemorrhage in 8 (2.5%) patients (associated with infrapopliteal thrombolysis in 5). At 30 days, primary and secondary patency rates were 94.3% and 97.2%, respectively; mortality was 0.3% (1 fatal intracranial hemorrhage after adjunctive thrombolysis). Of 229 patients eligible for 1-year follow-up, amputation-free survival was estimated to be 87.4% in 199 patients with available data. CONCLUSION: In this all-comers study, mechanical debulking with the Rotarex alone or with adjunctive techniques is feasible as a primary therapy for occluded supratibial vessels in patients with ALI or SLI.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023905
- 003
- CZ-PrNML
- 005
- 20240424111216.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/1526602819840697 $2 doi
- 035 __
- $a (PubMed)30955402
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bulvas, Miroslav $u 1 Cardiocenter, Third Faculty of Medicine, Charles University, and Department of Surgery, Division of Interventional Angiology, University Hospital Královské Vinohrady, Prague, Czech Republic.
- 245 10
- $a Prospective Single-Arm Trial of Endovascular Mechanical Debulking as Initial Therapy in Patients With Acute and Subacute Lower Limb Ischemia: One-Year Outcomes / $c M. Bulvas, Z. Sommerová, I. Vaněk, J. Weiss,
- 520 9_
- $a PURPOSE: To report the results of a prospective, single-arm study to establish whether the initial treatment of acute or subacute limb ischemia (ALI and SLI, respectively) can be accomplished successfully using endovascular mechanical debulking of the target vessels to avoid the risks associated with thrombolysis and/or open surgery. MATERIALS AND METHODS: From April 2009 to April 2015, 316 consecutive patients (mean age 70.9±12 years; 184 men) with ALI (202, 63.9%) or SLI (114, 36.1%) were enrolled; the only exclusion criterion was irreversible ischemia. The ALI group included 146 (72.3%) participants with category IIb ischemia and 56 (27.7%) with category IIa. Critical limb ischemia was diagnosed in 74 (64.9%) of the 114 patients with SLI. Target occlusions of thrombotic (n=256) or embolic (n=60) origin were located in the femoropopliteal segment (n=231), prosthetic or venous femoropopliteal bypass grafts (n=75), and the aortoiliac segment (n=35). The mean occlusion length was 22.9±14.8 cm. RESULTS: The overall technical success (residual stenosis ≤30%) was 100% after debulking and adjunctive techniques (aspiration, dilation, stenting) at the level of the target lesions. No open surgical or thrombolytic modalities were necessary to bypass or recanalize the target vessels, and no death occurred in association with target occlusion therapy. Additional infrapopliteal interventions were performed in 195 (61.7%) patients (adjunctive thrombolysis in 29) to treat acute, subacute, and chronic lesions. Minor complications directly related to the debulking procedure occurred in 26 (8.2%) patients. Serious complications occurred in 11 (3.5%) patients, including hemorrhage in 8 (2.5%) patients (associated with infrapopliteal thrombolysis in 5). At 30 days, primary and secondary patency rates were 94.3% and 97.2%, respectively; mortality was 0.3% (1 fatal intracranial hemorrhage after adjunctive thrombolysis). Of 229 patients eligible for 1-year follow-up, amputation-free survival was estimated to be 87.4% in 199 patients with available data. CONCLUSION: In this all-comers study, mechanical debulking with the Rotarex alone or with adjunctive techniques is feasible as a primary therapy for occluded supratibial vessels in patients with ALI or SLI.
- 650 _2
- $a akutní nemoc $7 D000208
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a amputace $7 D000671
- 650 12
- $a endovaskulární výkony $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D057510
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ischemie $x diagnostické zobrazování $x mortalita $x patofyziologie $x terapie $7 D007511
- 650 _2
- $a záchrana končetiny $7 D023821
- 650 _2
- $a dolní končetina $x krevní zásobení $7 D035002
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a onemocnění periferních arterií $x diagnostické zobrazování $x mortalita $x patofyziologie $x terapie $7 D058729
- 650 _2
- $a doba přežití bez progrese choroby $7 D000077982
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a trombektomie $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D017131
- 650 _2
- $a trombolytická terapie $7 D015912
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a průchodnost cév $7 D014654
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sommerová, Zuzana $u 2 Department of Internal Medicine 2, University Hospital Královské Vinohrady, Prague, Czech Republic.
- 700 1_
- $a Vaněk, Ivan, $u 1 Cardiocenter, Third Faculty of Medicine, Charles University, and Department of Surgery, Division of Interventional Angiology, University Hospital Královské Vinohrady, Prague, Czech Republic. $d 1942-2023 $7 jn20000402486
- 700 1_
- $a Weiss, Jiří $u 1 Cardiocenter, Third Faculty of Medicine, Charles University, and Department of Surgery, Division of Interventional Angiology, University Hospital Královské Vinohrady, Prague, Czech Republic.
- 773 0_
- $w MED00008736 $t Journal of endovascular therapy $x 1545-1550 $g Roč. 26, č. 3 (2019), s. 291-301
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30955402 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20240424111212 $b ABA008
- 999 __
- $a ok $b bmc $g 1596224 $s 1114581
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 26 $c 3 $d 291-301 $e 20190406 $i 1545-1550 $m Journal of endovascular therapy $n J Endovasc Ther $x MED00008736
- LZP __
- $a Pubmed-20201125